Economic Impact of Treatment with Novel oral Anticoagulants Versus Warfarin in Brazilian Private Health System
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.093
https://www.valueinhealthjournal.com/article/S1098-3015(16)00161-3/fulltext
Section Title :
Cardiovascular Disorders - Cost Studies
Section Order :
1429
First Page :
A44
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00161-3&doi=10.1016/j.jval.2016.03.093